CNB-CSIC vaccine fully protects against SARS-CoV-2 infection of the brain

By | January 13, 2023
In a recent study published in the journal Nature Neuroscience, researchers in Spain described the effectiveness of a modified vaccinia virus Ankara (MVA) vector severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)  vaccine candidate in protecting against SARS-CoV-2 infection in the brain using a mouse model.